| Literature DB >> 30012993 |
Tamra N Tolen1, Yicheng Xie2, Thomas B Hairgrove3, Jason J Gill4, T Matthew Taylor5.
Abstract
Microbiological safety of beef products can be protected by application of antimicrobial interventions throughout the beef chain. This study evaluated a commercial prototype antimicrobial intervention comprised of lytic bacteriophages formulated to reduce O157 and non-O157 Shiga-toxigenic Escherichia coli (STEC) on beef cattle hide pieces, simulating commercial pre-harvest hide decontamination. STEC reduction in vitro by individual and cocktailed phages was determined by efficiency of plating (EOP). Following STEC inoculation onto hide pieces, the phage intervention was applied and hide pieces were analyzed to quantify reductions in STEC counts. Phage intervention treatment resulted in 0.4 to 0.7 log10 CFU/cm² (p < 0.01) E. coli O157, O121, and O103 reduction. Conversely, E. coli O111 and O45 did not show any significant reduction after application of bacteriophage intervention (p > 0.05). Multiplicity of infection (MOI) evaluation indicated E. coli O157 and O121 isolates required the fewest numbers of phages per host cell to produce host lysis. STEC-attacking phages may be applied to assist in preventing STEC transmission to beef products.Entities:
Keywords: Shiga-toxigenic E. coli; bacteriophages; beef safety; biocontrol; cattle hides; pre-harvest
Year: 2018 PMID: 30012993 PMCID: PMC6068917 DOI: 10.3390/foods7070114
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Phage titer and efficiency of plating characterization of Shiga-toxigenic E. coli (STEC) by phages.
| STEC Isolate 1 | Sero-ID | Phage Cocktail Titer (log10 PFU/mL) 2 | Phage Efficiency of Plating (EOP) | ||||
|---|---|---|---|---|---|---|---|
| Phage A | Phage B | Phage C | Phage D | Phage Cocktail 4 | |||
| USDA-FSIS 380-94 | O157:H7 | 8.6 ± 0.1 | - | 0.19 3 | 1.0 | + | 1.0 |
| CDC 96-3258 | O45:H2 | 8.3 ± 0.1 | + | 0.08 | - | + | 0.5 |
| CDC 90-3128 | O103:H2 | 8.4 ± 0.5 | + | 1.0 | 0.42 | 0.25 | 1.0 |
| JB1-95 | O111:H- | 9.1 ± 0.1 | 1.0 | - | - | 0.29 | 3.3 |
| CDC 97-3068 | O121:H19 | 6.7 ± 0.1 | - | - | - | 0.08 | 0.01 |
1 STEC isolates provided by J.B. Luchansky (USDA-Agricultural Research Service, Wyndmoor, PA, USA). 2 Values depict mean ± one standard deviation (N = 3) of phages plated for corresponding STEC isolate. 3 EOP calculated as phage titer on test STEC isolate divided by phage titer on the E. coli O157:H7 isolate for phages A, B, and C. EOP for phage D was normalized to phage titer on E. coli O27:H11 isolate H30 (data not shown). -: no observed plaques or clearing zones formed at any phage dilution; +: confluent spot formation at 10−1–10−2 phage dilutions but no isolated plaques observed. 4 EOP calculated as observed phage titer on the STEC isolate divided by phage titer for E. coli O157:H7 isolate.
Figure 1Growth or inhibition of Shiga-toxigenic E. coli (STEC) isolates in vitro as a function of phage dilution. Symbols depict mean optical density at 550 nm (OD550) from triplicate identical replicates (N = 3) for STEC isolates grown in the absence (Control; ●), phages diluted 10−1 from commercial phage intervention (▲), phages diluted 10−2 (∎) phages diluted 10−3 (◆), or phages diluted 10−4 (⋆). Panels relate the growth of E. coli O157:H7 (A), O45:H2 (B), O103:H2 (C), O111:H- (D), or O121:H19 (E).
Survival of Shiga-toxigenic Escherichia coli (STEC) isolates on beef cattle hide pieces by the application of antimicrobial treatment and the multiplicity of infection of phages: STEC host.
| STEC Isolate 1. | Sero-ID | Phages | Water | Control | Phage:Host MOI 3 |
|---|---|---|---|---|---|
| USDA-FSIS 380-94 | O157:H7 | 5.6 ± 0.2B 2 | 6.1 ± 0.2A | 6.1 ± 0.3A | 11.2 |
| CDC 96-3258 | O45:H2 | 5.8 ± 0.1AB | 5.9 ± 0.1AB | 5.8 ± 0.2AB | 47.3 |
| CDC 90-3128 | O103:H2 | 5.2 ± 0.4C | 6.0 ± 0.2A | 5.9 ± 0.2AB | 15.6 |
| JB1-95 | O111:H- | 5.9 ± 0.1A | 5.9 ± 0.2AB | 6.0 ± 0.2A | 41.7 |
| CDC 97-3068 | O121:H19 | 4.7 ± 0.3D | 5.1 ± 0.1C | 5.1 ± 0.2C | 2.2 |
1 STEC isolates provided by J.B. Luchansky (USDA-Agricultural Research Service, Wyndmoor, PA, USA). 2 Values depict least squares means (log10 CFU/cm2) of STEC counts determined from analysis of variance. Values not sharing common letters (A,B,C,D) differ at p = 0.05 by Tukey’s Honestly Significant Differences (HSD) multiple comparisons test. Surviving STEC were enumerated on tryptic soy agar supplemented with 100.0 µg/mL rifampicin. Triplicate identical replicates were completed bearing three identically treated samples per replicate (N = 9). Antimicrobial treatments were: (1) STEC-inoculated non-treated group (Control); (2) STEC-inoculated, sterile distilled water (25 °C); and (3) STEC-inoculated with 108 PFU/mL phage intervention-treated. 3 MOI: Phage multiplicity of infection (MOI) applied in the hide intervention study, calculated as the number of phages applied to hide surfaces divided by the number of bacteria retained on hide surfaces post-inoculation.